# US 2021/0259890 A1 · Medical Adhesives For Quick Release Of Antimicrobials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0259890 A1
- Document ID: US20210259890A1
- Status: Published application
- Kind: A1
- Application number: 17/251,160
- Filed: 2019-06-12
- Published: 2021-08-26
- Earliest claimed: 2018-06-13
- Assignees: Avery Dennison Corporation
- Applicants: Avery Dennison Corporation
- Inventors: Neal CARTY; Jilin ZHANG
- Web page: https://patentgrep.com/patent/US20210259890A1

## CPC

- A61F 13/0253: {characterized by the adhesive material}
- A61L 15/18: containing inorganic materials
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A61L 15/58: Adhesives
- C08L 1/02: Cellulose; Modified cellulose
- C09J 133/04: Homopolymers or copolymers of esters {(C09J143/04 takes precedence)}
- A61F 2013/00663: {acrylic}
- A61F 2013/00702: {silicon-based}
- A61F 2013/0091: {with disinfecting or anaesthetics means, e.g. anti-mycrobic}
- A61L 2300/206: Biguanides, e.g. chlorohexidine
- A61L 2300/232: Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- C09J: ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES (preparation of glue or gelatine C09H)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Provided herein are adhesive compositions comprising: 1) at least one adhesive of an alcohol-functionalized acrylic adhesive, an alcohol-functionalized silicone adhesive, a carboxyl-functionalized acrylic adhesive, and a carboxyl-functionalized silicone adhesive, 2) at least one phase-separated hydrophilic material, and 3) at least one bioactive compound. At least one bioactive compound may comprise an antimicrobial agent. The adhesive compositions can quickly release an antimicrobial agent and cause the rapid onset of antimicrobial effects. Also provided are adhesive products and methods using the disclosed adhesive composition.

## Claims

### Claim 1

An adhesive composition comprising:
at least one adhesive, wherein the adhesive comprises at least one adhesive of an alcohol-functionalized acrylic adhesive, an alcohol-functionalized silicone adhesive, a carboxyl-functionalized acrylic adhesive, and a carboxyl-functionalized silicone adhesive;
at least one phase-separated hydrophilic material; and
at least one bioactive compound.

### Claim 2 (depends on 1)

The adhesive composition of claim 1, wherein at least one adhesive is a pressure sensitive adhesive.

### Claim 3 (depends on 1)

The adhesive composition of claim 1, wherein at least one adhesive is a hybrid adhesive.

### Claim 4 (depends on 1)

The adhesive composition of claim 1, wherein a concentration of at least one adhesive in the adhesive composition ranges from about 60 wt % to about 95 wt %.

### Claim 5 (depends on 1)

The adhesive composition of claim 1 wherein a concentration of the phase-separated hydrophilic material in the adhesive composition ranges from about 2 wt % to about 40 wt %.

### Claim 6 (depends on 1)

The adhesive composition of claim 1, wherein a concentration of the bioactive compound in the adhesive composition ranges from about 1 wt % to about 10 wt %.

### Claim 7 (depends on 1)

The adhesive composition of claim 1, wherein at least one phase-separated hydrophilic material comprises silicon dioxide, zinc oxide, titanium dioxide, calcium carbonate, starches, crystalline cellulose, microcrystalline cellulose, carboxylmethyl cellulose, crospovidone, clay, or combinations thereof.

### Claim 8 (depends on 7)

The adhesive composition of claim 7, wherein the microcrystalline cellulose comprises less than about 40 wt % of the adhesive composition.

### Claim 9 (depends on 1)

The adhesive composition of claim 1, wherein the concentration of the phase-separated hydrophilic material in the adhesive composition ranges from about 7 wt % to about 15 wt % and the concentration of the adhesive in the adhesive composition ranges from about 80 wt % to about 90 wt %.

### Claim 10 (depends on 1)

The adhesive composition of claim 1, wherein at least one bioactive compound comprises an antimicrobial agent.

### Claim 11 (depends on 10)

The adhesive composition of claim 10, wherein the antimicrobial agent comprises a bis-biguanide salt.

### Claim 12 (depends on 11)

The adhesive composition of claim 11, wherein the bis-biguanide salt comprises a chlorhexidine salt.

### Claim 13 (depends on 12)

The adhesive composition of claim 12, wherein the chlorhexidine salt comprises chlorhexidine digluconate.

### Claim 14 (depends on 1)

The adhesive composition of claim 1, having a release rate of the bioactive compound into water, and wherein the release rate is at least about 50 μg/cm2 within 90 minutes of contact of the adhesive composition with water.

### Claim 15 (depends on 1)

The adhesive composition of claim 1, having a release rate of the bioactive compound into water, and wherein the release rate is at least about 75 μg/cm2 within 90 minutes of contact of the adhesive composition with water.

### Claim 16 (depends on 1)

The adhesive composition of claim 1, having a release rate of the bioactive compound into water, and wherein the release rate is at least about 100 μg/cm2 within 90 minutes of contact of the adhesive composition with water.

### Claim 17 (depends on 1)

The adhesive composition of claim 1, wherein a release rate of the bioactive compound into water is at least about 120 μg/cm2 within 90 minutes of contact of the adhesive composition with water.

### Claim 18 (depends on 1)

The adhesive composition of claim 1, wherein the phase-separated hydrophilic material comprises microcrystalline cellulose, wherein the bioactive compound comprises chlorhexidine digluconate, and wherein the release rate is at least about 120 μg/cm2 within 90 minutes of contact of the adhesive composition with water.

### Claim 19 (depends on 1)

The adhesive composition of claim 1, wherein the concentration the bioactive compound in the adhesive composition ranges from about 4 wt % to about 8 wt %, wherein the concentration of the adhesive ranges from about 80 wt % to about 90 wt %, and wherein the release rate is at least about 120 μg/cm2 within 90 minutes of contact of the adhesive composition with water.

### Claim 20 (depends on 1)

The adhesive composition of claim 1, having antimicrobial activity resulting in at least a 4 log reduction in a Pseudomonas aeruginosa population within 90 minutes of contact of the adhesive composition with the population.

### Claim 21 (depends on 1)

The adhesive composition of claim 1, having antimicrobial activity resulting in at least a 4 log reduction in an Escherichia coli population within 90 minutes of contact of the adhesive composition with the population.

### Claim 22 (depends on 1)

The adhesive composition of claim 1, having antimicrobial activity resulting in at least a 4 log reduction in a Staphylococcus aureus population within 90 minutes of contact of the adhesive composition with the population.

### Claim 23 (depends on 1)

The adhesive composition of claim 1, having antimicrobial activity resulting in at least a 4 log reduction in a Candida albicans population within 90 minutes of contact of the adhesive composition with the population.

### Claim 24 (depends on 1)

The adhesive composition of claim 1, having antimicrobial activity resulting in at least a 0.1 log reduction in an Aspergillus brasiliensis population within 90 minutes of contact of the adhesive composition with the population.

### Claim 25 (depends on 1)

The adhesive composition claim 1, having a cytotoxicity grade of less than or equal to 2.

### Claim 26 (depends on 1)

The adhesive composition of claim 1, having a Primary Irritation Index value of less than or equal to 2.

### Claim 27 (depends on 1)

An adhesive product comprising:
a substrate layer; and
an adhesive layer disposed on at least a portion of a surface of the substrate layer, wherein the adhesive layer comprises the adhesive composition of claim 1.

### Claim 28 (depends on 27)

The adhesive product of claim 27, wherein the substrate layer comprises a polyethylene film, a polyurethane film, a polyvinylchloride film, a polyethylene foam, a polyurethane foam, a polyvinylchloride foam, nonwoven polyurethane, nonwoven elastomeric polyester, knitted fabric, woven fabric, or combinations thereof.

### Claim 29 (depends on 27)

The adhesive product of claim 27, wherein the substrate layer comprises a waterproof, flexible, non-adhesive film.

### Claim 30 (depends on 27)

The adhesive product of claim 27, wherein the adhesive product is configured for conformable topical application to biological skin.

### Claim 31 (depends on 27)

The adhesive product of claim 27, wherein the adhesive product is a pressure sensitive adhesive bandage, a wound covering, a medical dressing, a surgical dressing, a surgical drape, a surgical tape, an incise drape, or a medical tape.

### Claim 32 (depends on 27)

The adhesive product of claim 27, wherein at least a portion of the adhesive layer directly contacts at least a portion of the substrate layer.

### Claim 33 (depends on 27)

The adhesive product of claim 27, further comprising:
a release liner.

### Claim 34 (depends on 27)

A method for the release of a bioactive compound to a subject, the method comprising:
providing the adhesive product of claim 27; and
contacting the adhesive layer of the adhesive product to a biological skin surface of the subject, thereby delivering the bioactive compound of the adhesive product to the subject.

### Claim 35 (depends on 34)

The method of claim 34, wherein the biological skin surface is proximate to a wound or surgical site of the subject.

### Claim 36 (depends on 34)

The method of claim 34, wherein the subject is human.

### Claim 37

A method for producing an adhesive composition, the method comprising:
providing: 1) at least one adhesive wherein the adhesive is at least one of an alcohol-functionalized acrylic adhesive, an alcohol-functionalized silicone adhesive, a carboxyl-functionalized acrylic adhesive, and a carboxyl-functionalized silicone adhesive, 2) at least one phase-separated hydrophilic material, and 3) at least one bioactive compound; and
combining the adhesive, the phase-separated hydrophilic material, and the bioactive compound to produce the adhesive composition.

### Claim 38 (depends on 37)

The method of claim 37, wherein the adhesive composition comprises:
about 60 wt % to about 95 wt % of the adhesive, wherein the adhesive is at least one adhesive of an alcohol-functionalized acrylic adhesive, an alcohol-functionalized silicone adhesive, a carboxyl-functionalized acrylic adhesive, and a carboxyl-functionalized silicone adhesive;
about 2 wt % to about 40 wt % of the phase-separated hydrophilic material; and
about 1 wt % to about 10 wt % of the bioactive compound.

### Claim 39 (depends on 37)

The method of claim 37, wherein the bioactive compound comprises chlorhexidine digluconate.

### Claim 40 (depends on 37)

The method of claim 37, wherein the phase-separated hydrophilic material comprises silicon dioxide, zinc oxide, titanium dioxide, calcium carbonate, starches, crystalline cellulose, microcrystalline cellulose, carboxylmethyl cellulose, crospovidone, clay, or combinations thereof.

### Claim 41 (depends on 37)

The method of claim 37, wherein the adhesive composition has a release rate of the bioactive compound into water, and wherein the release rate is at least about 50 μg/cm2 within 90 minutes of contact of the adhesive composition with water.
